2006). Previous studies with a lung cancer cell line (A549 cells) have demonstrated that measurement of unspliced GM-CSF nRNA may be used as a surrogate for transcription rate (Newton et al. 2001). This evidence concerns the gene CSF2 and lung carcinoma.